A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
Clinical trial NCT05276310 · RECRUITING
Trial details
- NCT number
- NCT05276310
- Sponsor
- ImmuneOncia Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-02
- Primary completion
- 2027-12-17
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.